KCM
Knoll Capital Management Portfolio holdings
AUM
$141M
This Quarter Return
-13.93%
1 Year Return
+51.8%
3 Year Return
+256.4%
5 Year Return
+482.18%
10 Year Return
+5,137.57%
AUM
$106M
AUM Growth
+$106M
(-21%)
Cap. Flow
+$553K
Cap. Flow
% of AUM
0.52%
Top 10 Holdings %
Top 10 Hldgs %
93.01%
Holding
19
New
1
Increased
2
Reduced
1
Closed
1
Top Buys
| 1 |
Applied Therapeutics
APLT
|
$5.72M |
| 2 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$850K |
| 3 |
BioXcel Therapeutics
BTAI
|
$447K |
Top Sells
| 1 |
Blackstone
BX
|
$3.33M |
| 2 |
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
|
$3.14M |
Sector Composition
| 1 | Healthcare | 92.65% |
| 2 | Financials | 3.42% |
| 3 | Materials | 1.97% |
| 4 | Communication Services | 1.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $29.2M | 27.41% | 857,494 | – | – |
|
2
Corbus Pharmaceuticals
CRBP
$115M
| $26.4M | 24.84% | 5,045,870 | – | – |
|
|
3
Applied Therapeutics
APLT
$71M
| $21M | 19.72% | 642,071 +175,000 | +37% | +$5.72M |
|
4
Abeona Therapeutics
ABEO
$350M
| $6.01M | 5.64% | 2,859,767 | – | – |
|
|
5
Blackstone
BX
$134B
| $3.65M | 3.42% | 80,000 -73,000 | -48% | -$3.33M |
|
6
Entera Bio
ENTX
$88.1M
| $3.27M | 3.08% | 1,741,363 | – | – |
|
|
EIGR
7
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $3.23M | 3.04% | 475,238 +125,000 | +36% | +$850K |
|
8
Anavex Life Sciences
AVXL
$828M
| $2.28M | 2.14% | 724,205 | – | – |
|
9
Lumen
LUMN
$5.1B
| $2.08M | 1.95% | 220,000 | – | – |
|
10
Exicure
XCUR
$35.4M
| $1.89M | 1.78% | 1,277,777 | – | – |
|
|
MTEM
11
DELISTED
Molecular Templates, Inc.
MTEM
| $1.51M | 1.42% | 113,905 | – | – |
|
12
Aldeyra Therapeutics
ALDX
$351M
| $1.41M | 1.32% | 569,405 | – | – |
|
13
Soligenix
SNGX
$10.1M
| $1.32M | 1.24% | 787,830 | – | – |
|
14
Dow Inc
DOW
$17.5B
| $877K | 0.82% | 30,000 | – | – |
|
15
Corteva
CTVA
$50.4B
| $705K | 0.66% | 30,000 | – | – |
|
|
OTRK
16
DELISTED
Ontrak
OTRK
| $655K | 0.62% | 43,034 | – | – |
|
17
DuPont de Nemours
DD
$32.2B
| $512K | 0.48% | 15,000 | – | – |
|
|
18
BioXcel Therapeutics
BTAI
$59M
| $447K | 0.42% | +20,000 | New | +$447K |
|
|
19
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$220M
| – | – | -96,000 | Closed | -$3.14M |
|